Dynamic Changes in Central and Peripheral Neuro-Injury vs. Neuroprotective Serum Markers in COVID-19 Are Modulated by Different Types of Anti-Viral Treatments but Do Not Affect the Incidence of Late and Early Strokes

The balance between neurodegeneration, neuroinflammation, neuroprotection, and COVID-19-directed therapy may underly the heterogeneity of SARS-CoV-2′s neurological outcomes. A total of 105 patients hospitalized with a diagnosis of COVID-19 had serum collected over a 6 month period to assess neuroinf...

Descripción completa

Detalles Bibliográficos
Autores principales: Laudanski, Krzysztof, Hajj, Jihane, Restrepo, Mariana, Siddiq, Kumal, Okeke, Tony, Rader, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698659/
https://www.ncbi.nlm.nih.gov/pubmed/34944606
http://dx.doi.org/10.3390/biomedicines9121791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698659/
https://www.ncbi.nlm.nih.gov/pubmed/34944606
http://dx.doi.org/10.3390/biomedicines9121791

Ejemplares similares